Superworth

Scinai Immunotherapeutics market cap SCNI

Share price times shares outstanding: what the whole company sells for, since 2020.

Today, Nov 2, 2026
$657.9M
Highest close in our data
$20.5B
Jul 2020

Scinai Immunotherapeutics is worth $657.9M at the close on Nov 2, 2026, at $0.47 a share.

That is down 81% over the last year and down 40% over five years.

Its highest close in our data was $20.5B in Jul 2020.

Market cap over time

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHighChange
2026 so far$657.9M$654.2M$10.2B−73%
2025$2.4B$364M$9.9B+287%
2024$620.3M$516.3M$835.7M−21%
2023$781.6M$100.9M$2.6B+361%
2022$169.7M$169.7M$963.1M−84%
2021$1.1B$705.8M$2.6B−15%
2020$1.3B$1.2B$20.5Bn/a

Against its peers

Companies in Biotechnology nearest Scinai Immunotherapeutics' size, closest first, today.

CompanyMarket cap
SCNIScinai Immunotherapeutics$657.9M
MGTXMeiraGTx$895.1M
VCELVericel$2.1B
PLXProtalix BioTherapeutics$206.3M
ADMAAdma Biologics$2.5B
Peer median$1.5B

What the market cap tells you

Share price times shares outstanding: what the whole company sells for today.

Size, not quality. Large caps move slower and are covered more. That is all it tells you.

More on Scinai Immunotherapeutics

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.